I third that sentiment. I get it that this pand
Post# of 148178
(Total Views: 398)
Posted On: 03/17/2020 10:22:04 AM
I third that sentiment.
I get it that this pandemic is crashing the economy and, yes, we can pursue multiple indications at once, but CV seems like a real longshot while we're on the doorstep of a blockbuster in HIV and even Cancer. I just want to finish something, and by finish I mean get the drug approved and licensed so we can sell it. The switching/adding new indications is textbook for the company since I got in. We're always chasing NASH, MS, Prostate test, GvHD, Coronavirus, and yet we're 2 years removed from reaching our primary endpoint on P3 for combo HIV and can't get a BLA submitted.
I get it that this pandemic is crashing the economy and, yes, we can pursue multiple indications at once, but CV seems like a real longshot while we're on the doorstep of a blockbuster in HIV and even Cancer. I just want to finish something, and by finish I mean get the drug approved and licensed so we can sell it. The switching/adding new indications is textbook for the company since I got in. We're always chasing NASH, MS, Prostate test, GvHD, Coronavirus, and yet we're 2 years removed from reaching our primary endpoint on P3 for combo HIV and can't get a BLA submitted.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼